Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose rate

Toxicological Sciences

Volumn 100, Issue 1, 2007, Pages 156-167

  Barber, David S ^a   Stevens, Stanley ^a   LoPachin, Richard M ^b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Adduct formation; Isotope coded affinity tag; Nerve terminal; Neurotoxicity; Proteomic analysis; Toxic neuropathy

Indexed keywords

ACRYLAMIDE; CYSTEINE; DOPAMINE TRANSPORTER; N ETHYLMALEIMIDE SENSITIVE FACTOR; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; FUNCTIONAL PROTEOMICS; INTOXICATION; LIQUID CHROMATOGRAPHY; MALE; NERVE ENDING; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SCORING SYSTEM; SYNAPTOSOME; TANDEM MASS SPECTROMETRY;

ACRYLAMIDE; ANIMALS; BASAL GANGLIA; BODY WEIGHT; CHROMATOGRAPHY, LIQUID; CYSTEINE; GAIT; ISOTOPE LABELING; MALE; NERVE TISSUE PROTEINS; NEUROTOXICITY SYNDROMES; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES; TANDEM MASS SPECTROMETRY; TIME FACTORS;

RATTUS;

EID: 35448985440     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm210     Document Type: Article

References (47)

1. Barber, D. S., and LoPachin, R. M. (2004). Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes. Toxicol. Appl. Pharmacol. 201, 120-136.
2. Bordini, E., Hamdan, M., and Righette, P. G. (2000). Probing acrylamide alkylation sites in cysteine-free proteins by matrix-assisted laser desorption/ionisation time-of-flight. Rapid Commun. Mass Spectrom. 14, 840-848.
3. Calakos, N., and Scheller, R. H. (1996). Synaptic vesicle biogenesis, docking and fusion: A molecular description. Physiol. Rev. 76 1-29.
4. Calingasan, N. Y., Uchida, K., and Gibson, G. E. (1999). Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72, 751-756.
5. Cheng, D., Hoogenraad, C., Rush, J., Ramm, E., Schlager, M., Duong, D., Xu, P., Wihayawardana, S., Hanfelt, J., Nakagawa, T., et al. (2006). Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol. Cell. Proteomics 5, 1158-1170.
6. Coleman, P. D., and Yao, P. J. (2003). Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 24, 1023-1027.
7. Crofton, K. M., Padilla, S., Tilson, H. A., Anthony, D. C., Raymer, J. H., and MacPhail, R. C. (1996). The impact of dose-rate on the neurotoxicity of acrylamide: The interaction of administered dose, target tissue concentrations, tissue damage and functional effects. Toxicol. Appl. Pharmacol. 139, 163-176.
8. Edwards, P. M., and Parker, V. H. (1977). A simple, sensitive and objective method for early assessment of acrylamide neuropathy in rats. Toxicol. Appl. Pharmacol. 40, 589-591.
9. Feng, Y., and Forgac, M. (1992). Cysteine 254 of the 73-kDa A subunit is responsible for inhibition of the coated vesicle (H+)-ATPase upon modification by sulfhydryl reagents. J. Biol. Chem. 267, 5817-5822.
10. Goldstein, B. D., and Lowndes, H. E. (1979). Spinal cord defect in the peripheral neuropathy resulting from acrylamide. NeuroToxicology 1, 75-87.
11. Goldstein, B. D., and Lowndes, H. E. (1981). Grouph primary afferent terminal defect in cats with acrylamide neuropathy. Neurotoxicology 2, 297-312.
12. Gygi, S. P., Rist, B., Griffin, T. J., Eng, J., and Aebersold, R. (2002). Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity targets. J. Proteome Res. 1, 47-54.
13. Hall, S. C., Smith, D. M., Masiarz, R. R., Soo, V. W., Tran, H. M., Epstein, L. B., and Burlinggame, A. L. (1993). Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanona lysates. Proc. Acad. Nat. Sci. U.S.A. 90, 1927-1931.
14. Hendrickson, E. L., Xia, Q., Wang, T., Leigh, J. A., and Hackett, M. (2006). Comparison of spectra counting and metabolic stable isotope labeling for use with quantitative microbial proteomics. Analyst 131, 1335-1341.
15. Jahn, R., Lang, T., and Sudhof, T. C. (2003). Membrane fusion. Cell 112, 519-533.
16. Johnson, E. C., and Murphy, S. D. (1977). Effects of acrylamide intoxication on pyridine nucleotide concentrations and functions in rat cerebral cortex. Biochem. Pharmacol. 26, 2151-2155.
17. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002). Empirical statistical model to estimate the accuracy of peptide identification made by MS/MS and database search. Anal. Chem. 74, 5383-5302.
18. Ku, R. H., and Billings, R. E. (1986). The role of mitochondrial glutathione and cellular protein sulfhydryls in formaladehyde toxicity in glutathionedepleted rat hepatocytes. Arch. Biochem. Biophys. 247, 183-189.
19. Kuperman, A. S. (1958). Effects of acrylamide on the central nervous system of the cat. J. Pharmacol. Exp. Ther. 123, 180-192.
20. Lehning, E. J., Balaban, C. D., Ross, J. F., and LoPachin, R. M. (2002a). Acrylamide neuropathy. I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum. Neurotoxicology 23, 397-414.
21. Lehning, E. J., Balaban, C. D., Ross, J. F., and LoPachin, R. M. (1002b). Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in rat forebrain. Neurotoxicology 23, 415-429.
22. Lehning, E. J., Balaban, C. D., Ross, J. F., and LoPachin, R. M. (2003). Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in rat forebrain. Neurotoxicology 24, 125-136.
23. Lehning, E. J., Persaud, A., Dyer, K. R., Jortner, B. S., and LoPachin, R. M. (1998). Biochemical and Morphologic characterization of acrylamide peripheral neuropathy. Toxicol. Appl. Pharmacol. 151, 211-221.
24. Liu, H., Sadygov, R. G., and Yates, J. R. (2004). A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201.
25. LoPachin, R. M. (2002). The role of fast axonal transport in acrylamide pathophysiology: Mechanism or epiphenomenon? Neurotoxicology 23 253-257.
26. LoPachin, R. M. (2004). The changing view of acrylamide neurotoxicity. Neurotoxicology 25, 617-630.
27. LoPachin, R. M., Balaban, C. D., and Ross, J. F. (2003). Acrylamide axonopathy revisited. Toxicol. Appl. Pharmacol. 188, 135-153.
28. LoPachin, R. M., and Barber, D. S. (2006). Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Toxicol. Sci. 94, 240-255.
29. LoPachin, R. M., Barber, D. S., Geohagen, B. C., Gavin, T., He, D., and Das, S. (2007a). Structure-toxicity analysis of Type-2 alkenes: In vitro neurotoxicity. Toxicol. Sci. 95, 136-146.
30. LoPachin, R. M., Barber, D. S., He, D., and Das, S. (2006). Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles. Toxicol. Sci. 89, 224-234.
31. LoPachin, R. M., and DeCaprio, A. P. (2005). Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 86, 214-225.
32. LoPachin, R. M., Gavin, T., Geohagen, B. C., and Das, S. (2007b). Neurotoxic mechanisms of electrophilic type-2 alkenes: Soft-soft interactions with nucleophilic targets. Toxicol. Sci. 98, 561-570.
33. LoPachin, R. M., Ross, J. F., and Lehning, E. J. (2002a). Nerve terminals as the primary site of acrylamide action: A hypothesis. Neurotoxicology 23, 43-60.
34. LoPachin, R. M. Ross, J. F., Reid, M. L., Dasgupta, S., Mansukhani, S., and Lehning, E. J. (2002b). Neurological evaluation of toxic axonopathies in rats: Acrylamide and 2,5-hexanedione. Neurotoxicology 23, 95-110.
35. LoPachin, R. M., Schwarcz, A. I., Gaughan, C. L., Mansukhani, S., and Das, S. (2004). In vivo and in vitro effects of acrylamide on synaptosomal neurotransmitter uptake and release. Neurotoxicology 25, 349-363.
36. Matsushita, K., Morrell, C. N., Cambien, M., Yamakuchi, M., Bao, M., Hara, R. A., Quick, W., Cao, J. M., Lowenstein, C. J., and Pevsner, J. (2003). Nitric oxide regulates exocytosis by S-nitrosylation of N ethylmaleimide sensitive factor. Cell 115, 139-150.
37. Matsushita, K., Morrell, C. N., Mason, R. J. A., Yamakuchi, M., Khanday, F. A., Irani, K., and Lowenstein, C. J. (2005). Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N ethylmaleimide sensitive factor. J. Cell Biol. 170, 73-79.
38. Nersvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003). A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658.
39. Park, S. U., Ferrer, J. V., Javitch, J. A., and Kuhn, D. M. (2002). Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: Potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22, 4399-4405.
40. Raiteri, L., and Raiteri, M. (2000). Synaptosomes still viable after 25 years of superfusion. Neurochem. Res. 25, 1265-1274.
41. Reim, K., Mansour, M., Vargoqueaux, F., McMahon, H. T., Sudhof, T. C., Brose, N., and Rosenmund, C. (2001). Complexins regulate a late step in Ca2+- dependent neurotransmitter release. Cell 104, 71-81.
42. Schrimpf, S. P., Meskenaite, V., Brunner, E., Rutishauser, D., Walther, P., Eng, J., Aebersold, R., and Sonderegger, P. (2005). Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics 5, 2531-2541.
43. Sethuraman, M., McComb, M. E., Heibeck, T., Costello, C. E., and Cohen, R. A. (2004). Isotope-coded affinity tag approach to identify and quantify oxidant-sensitive protein thiols. Mol. Cell. Proteomics 3, 273-278.
44. Sickles, D. W., Stone, J. D., and Friedman, M. A. (2002). Fast axonal transport: A site of acrylamide neurotoxicity? Neurotoxicology 23, 223-251.
45. Stamler, J. S., Lamas, S., and Fang, F. C. (2001). Nitrosylation: The prototypic redox-based signaling mechanism. Cell 106, 675-683.
46. Tang, J., Moximov, A., Shin, O. -H., Dai, H., Rizo, J., and Sudhof, T. C. (2006). A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell 126, 1175-1187.
47. Whiteheart, S. W., Schraw, T., and Mateeva, E. A. (2001). N-ethylmaleimide sensitive factor (NSF) structure and function. Int. Rev. Cytol. 207, 71-112.